Citations |
Acta Pharmacol Sin. 2021 Jan;42(1):108-114.<br>Am J Cancer Res. 2021 Apr 15;11(4):1428-1445.<br>bioRxiv. 2023 Jul 25.<br>bioRxiv. 2023 Jun 3.<br>bioRxiv. 2023 Sep 16.<br>Cancer Immunol Res. 2023 May 3;11(5):583-599.<br>Cancers (Basel). 2021, 13(13), 3323.<br>Cell Chem Biol. 2020 Nov 19;27(11):1359-1370.e8.<br>Cell Rep Med. 2024 Mar 19;5(3):101468.<br>Cell. 2024 Apr 25;187(9):2288-2304.e27.<br>Eur J Med Chem. 2018 Feb 25;146:157-170.<br>Front Microbiol. 2019 May 9;10:939. <br>Front Oncol. 2021 Apr 22;11:665763.<br>Front Oncol. 2021 Apr 6.<br>Hum Exp Toxicol. 2021 Feb 4;960327121991901.<br>Int J Biol Macromol. 2019 Jan 30;128:574-582.<br>Int J Nanomedicine. 2017 Mar 16;12:2081-2108.<br>J Chromatogr B. 2021, 122591.<br>J Clin Invest. 2024 Mar 7:e172716.<br>Leuk Lymphoma. 2020 Feb;61(2):420-428.<br>Leukemia. 2021 Mar 29.<br>Mol Ther. 2021 Jul 1;S1525-0016(21)00353-1.<br>Neurobiol Learn Mem. 2019 Sep;163:107038.<br>Oncotarget. 2017 Dec 2;8(68):112313-112329.<br>Pharmacol Res. 2024 May 9:204:107208.<br>Sci Adv. 2023 Feb 10;9(6):eade9238.<br>Sci Rep. 2019 Aug 12;9(1):11677.<br>SLAS Discov. 2024 Feb 12;29(2):100147.<br>Biochem Biophys Res Commun. 2023 Jun 27;674:27-35.<br>Biomed Pharmacother. 2020 May;125:110003.<br>bioRxiv. 2023 Apr 14.<br>bioRxiv. 2023 Feb 27.<br>bioRxiv. 2019 Dec.<br>Breast Cancer Res Treat. 2023 May 19.<br>Cancers (Basel). 2022 Oct 19;14(20):5127.<br>Cell Mol Immunol. 2023 Jan;20(1):51-64.<br>DRUG RESIST UPDATE. 2023 Feb 13;68:100951.<br>Front Oncol. 2020 Mar 13;10:308.<br>Front Pharmacol. 15 July 2022.<br>J Biomed Inform. 2023 May 15;104383.<br>J Transl Med. 2023 Jan 9;21(1):9.<br>Mol Pharm. 2022 Oct 21.<br>[1]Gidding, C.E., et al, Vincristine revisited. Crit Rev Oncol Hematol, 1999. 29(3): p. 267-87.<br>[2]Jordan, M.A., et al. Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro. Cancer Res, 1985. 45(6): p. 2741-7.<br>[3]Baguley, B.C., et al, Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism. Eur J Cancer, 1991. 27(4): p. 482-7.<br>[4]Zhang D, et al. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance. Int J Nanomedicine. 2017 Mar 16;12:2081-2108.<br>[5]Donoso, J.A., et al, Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on axonal fibrillar organelles in vitro. Cancer Res, 1977. 37(5): p. 1401-7.<br>[6]Horton, J.K., et al. Relationships between tumor responsiveness, vincristine pharmacokinetics and arrest of mitosis in human tumor xenografts. Biochem Pharmacol, 1988. 37(20): p. 3995-4000. |